Literature DB >> 6928244

A new mouse tumor model system (RIF-1) for comparison of end-point studies.

P R Twentyman, J M Brown, J W Gray, A J Franko, M A Scoles, R F Kallman.   

Abstract

A new tumor model system (RIF-1) was developed that is very suitable for studies in which clonogenic survival is compared with growth delay and control probability following various forms of treatment. The tumor was a radiation-induced sarcoma in the inbred female C3H/Km mouse. It had a low median tumor dose, had a satisfactory plating efficiency direct from in vivo to in vitro, was nonimmunogenic or minimally immunogenic, and metastasized only at a relatively advanced stage of growth. The cell line grew either as a monolayer on plastic dishes, as tumor spheroids in spinner culture, as lung nodules following injection of a single-cell suspension into the tail veins of syngeneic mice, or as a solid tumor. Both diploid and tetraploid clonogenic cells were found in monolayer cultures of the RIF-1 line.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6928244

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  86 in total

1.  DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.

Authors:  M J Dorie; M S Kovacs; E C Gabalski; M Adam; Q T Le; D A Bloch; H A Pinto; D J Terris; J M Brown
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Tumor vascular microenvironment determines responsiveness to photodynamic therapy.

Authors:  Amanda L Maas; Shirron L Carter; E Paul Wileyto; Joann Miller; Min Yuan; Guoqiang Yu; Amy C Durham; Theresa M Busch
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

3.  Deficiency in Bre1 impairs homologous recombination repair and cell cycle checkpoint response to radiation damage in mammalian cells.

Authors:  Sophia B Chernikova; Jennifer A Dorth; Olga V Razorenova; John C Game; J Martin Brown
Journal:  Radiat Res       Date:  2010-08-25       Impact factor: 2.841

4.  Metabolite specific proton magnetic resonance imaging.

Authors:  R E Hurd; D M Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Cell survival assays in a slowly dividing normal tissue.

Authors:  H Walker; R Ahier; P Coultas
Journal:  Br J Cancer Suppl       Date:  1986

6.  Improved assay of stromal injury based on the number of tumour cells that can be supported by irradiated flank skin.

Authors:  M Penhaligon; R S Camplejohn
Journal:  Br J Cancer Suppl       Date:  1986

7.  Dynamic heterogeneity: experimental metastasis studies with RIF-1 fibrosarcoma.

Authors:  B M Korycka; R P Hill
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

8.  Does the mode of heat induction modify drug anti-tumour effects?

Authors:  G M Hahn
Journal:  Br J Cancer Suppl       Date:  1982-03

9.  Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice.

Authors:  C S Johnson; M J Chang; W D Yu; R A Modzelewski; J R Grandis; D R Vlock; P Furmanski
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015.

Authors:  William J Bodell; Donald D Giannini; Saira Singh; Dennis Pietronigro; Victor A Levin
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.